ìåâå
úîåðä ùì àéùä
àúø äîåîçéí ùì éùøàì
button
button
button
button
button
button
button
button
ãåà"ì:
ñéñîä:
æëåø àåúé
äéøùí ìàúø ë îåîçä-òñ÷ / çáø-âåìù
òáøðå ìàñ÷éîå îåîçéí áåéãàå-ö'è - àúí îåæîðéí ìäöèøó àìéðå askimo.co.il

%>
áøéàåú åøôåàä
áøéàåú äàéùä
áøéàåú äâáø
áøéàåú äéìã
áøéàåú äðôù
áøéàåú åëéøåøâéä
áøéàåú åøôåàä - ëììé
áøéàåú òåø åàñúèé÷ä
ãú åéäãåú
äáéú åäâéðä
äðãñä åúëðåï
çå÷ åîùôè
çéðåê åäåøàä
ëìëìä åòñ÷éí
îãòé äçáøä
îãòé äèáò åäñáéáä
îãòé äøåç
îåãòåú åøåçðéåú
îçùáéí åàéðèøðè
îéãòðåú åéòåõ
îîùì åáèçåï
îùôçä åäåøåú
ñèåãðèéí åà÷ãîééä
ôðàé åúøáåú
ôñéëåìåâéä åúøôéä
øëá åúçáåøä
øôåàä åáøéàåú
øôåàä îùìéîä
ùéåå÷ åôéúåç òñ÷é
ùôåú åòøéëä
úéëåï åáâøåéåú
ááéìåï

øåöä ìäúééòõ òí îåîçéí áåéãàå? ìçõ ëàï

ùàìåú åúùåáåú - øôåàú òéðééí
 

îåîçé KOL áúçåí øôåàä åáøéàåú >> øôåàú òéðééí :
ãø' éðéá áø÷ðà MD, ãø' éâàì ìéáåáéõ MD, ãø' ãåã ìðãàå MD, ãø' ãåéã öãå÷

ôðä ìòñ÷ / îåîçä áøôåàú òéðééí

øôåàä åáøéàåú >> øôåàú òéðééí

ùìåí øá
ìçáøúé îâéì

ùìåí øá
ìçáøúé îâéì 4 ìòøê àåáçðä îçìú òéðééí áùí choroidal osteoma øàééúä äéãøãøä áîùê äùðéí òã ìîöá áå äéà øåàä áëáãåú øáä áòéï àçú åáòéï äùðéä ëîòè åìà øåàä. îöá æä ðùàø éöéá éçñéú áùðéí äàçøåðåú. (éù ìöééï ëé àçéä ñáì âí äåà îîçìä æå åäåà ëòú àéðå øåàä).áæîðå ìôðé ë17 ùðä ðéñå ùéèú èéôåì áàøä"á àùø ìà öìçä åééúëï ëé äæé÷ä. áùàìúé äééúé îòåðééï ìãòú äàí éùðí ùéèåú èéôåì çãùåú àùø ðåñå áùðéí äàçøåðåú åäöìéçå? äàí îçìä æå äéðä úåøùúéú åòåáøú áãåøåú äáàéí åàí ëï îäå àçåæ ääòáøä? àéæä îãéðåú ëéåí òåñ÷åú áúçåí æä àùø àôùø ìäéååòõ åì÷áì èéôåì? åáàåôï ëììé îéãò òì äîçìä.
áúåãä øáä(î÷ååä ì÷áì úùåáä îñô÷ú)

Choroidal Osteoma ðçùáú âéãåì ùôéø (ìà îîàéø) ùì äòéï åîàåôéï áäúôúçåú ø÷îú òöí áøùúéú áçì÷ îäî÷øéí áòéï àçú åáàçøéí áùúé äòéðééí. âéãåì æä ùëéç éåúø áðùéí îàùø áâáøéí åéù ðèéä îùôçúéú (ðéúï ìîöà îöá æä âí áàçéí åàçéåú ùì çåìä). ìà îöàúé áñôøåú äî÷öåòéú àáçåï ùì âï ñôöéôé àå àéúåø ùì ãøê äòáøä âðèéú îåëçú.

ìöòøé âéãåì æä îú÷ãí áàåôï àéèé ìàåøê ùðéí åìòéúéí ÷øåáåú ôåâò ÷ùåú áøàéä òã ëãé òéååøåï.äôâéòä áøàéä ðåáòú îúäìéëéí ä÷åøéí áâéãåì ëîå ãìó îëìé ãí åäöèáøåú ðåæìéí îúçú ìøùúéú,äåôòú ëìé ãí çãùéí ìà ú÷éðéí áàéæåø äâéãåì àå ãä÷ìöéôé÷öéä ùì äòöí áâéãåì.

ìà îöàúé áñôøåú äöòä ìôúåôéæéåìåâéä ùì äâéãåì.
îëéååï ùîãåáø áâéãåì ùôéø ãé ðãéø, ëîåú äîéãò åäðéñéåï ä÷ìéðé áèéôåì áî÷øéí àéìå ÷èï éçñéú.

äèéôåì áâéãåì æä îàëæá îàåã, áòáø ðéñå ìâøåí ìðñéâä ùìå òì éãé öøéáä á÷øðé ìééæø - photocoagulation ììà äöìçä.
ìà îöàúé áñôøåú äòãëðéú, äöòä ìùéèú èéôåì çãùä.

äñãøä äâãåìä áéåúø ùôåøñîä äâéò îäàåðéáøñéèä ùì îéàîé ëê ùðéúï ìùòø ùùí éù âí ðéñéåï åîç÷ø áúçåí æä.



äúùåáä ðéúðä òì éãé îåîçä KOL ãø' ãåã ìðãàå MD

îçìä æå äéà ðãéøä, øá øåôàé äòéðééí àéðí ðú÷ìéí àôéìå áî÷øä àçã áîùê çééäí. åîáéï äî÷øéí äîòèéí ùì äîçìä, äî÷øéí äîùôçúééí, áäí éåúø îáï îùôçä àçã çåìä, äéðí ìà àåôééðééí åðãéøéí. îëàï áøåø ùàúä æ÷å÷ ìîåîçä ùòåñ÷ ø÷ áúçåí æä. éù áéùøàì ø÷ øåôà àçã ëæä, ôøåôñåø ôàø, îðäì îçì÷ú òéðééí ááéä"ç äãñä, éøåùìéí. àí ðéúï ìòùåú îùäå ìùéôåø äøàééä, áëì àîöòé ùäåà àå áëì î÷åí áòåìí, åàí ðéúï ìúú ééòåõ úåøùúé, äåà ééãò. ëîåáï ìàçø áãé÷ú äçåìä åñ÷éøä ùì îñîëé òáøä äøôåàé. ìëï òöúé äéà ùàí çáøúê ìà ðáã÷ä òì-éãå áùðéí äàçøåðåú, ì÷áåò ôâéùä. àí çôöëí áééòåõ òãëðé áçå"ì, (ä)îøëæ (ä)îåáéì ùòåñ÷ ø÷ áâéãåìéí òéðééí äéðå ä The Ocular Oncology Service of Wills Eye Hospital, Thomas Jefferson University áäðäìúå ùì ã"ø ùéìãñ, áôéìãìôéä. ôøèé áéú äçåìéí á
http://www.eyecancerinfo.com/index.htm
ðéúï âí ìùìåç ìäí ùàìä áãåà"ì ãøê äàúø http://www.eyecancerinfo.com/Pages/faqs.htm

äúùåáä ðéúðä òì éãé îåîçä KOL ãø' éðéá áø÷ðà MD

[23643]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

áòìé áï 52 åñåáì

áòìé áï 52 åñåáì îæä ëòùøéí ùðä îîçìú òéðééí áùí øèéðéèéñ ôéâîðèåæä. îöáå äéãøãø áîäìê äùðéí åëéåí äåà îñåâì ìäáçéï áéï çåùê ìàåø áìáã.
ìàçøåðä ÷øàúé òì îç÷øéí çãùéí ùðòùéí áúçåí, åøöéúé ì÷áì ééòåõ åäëååðä ìàéðôåøîöéä ðåñôú åìâåøîéí øìååðèéí äéëåìéí ìñééò.

øèéðéèéñ ôéâîðèåæä äéà îçìä ðéååðéú îú÷ãîú ùì äøùúéú áòìú îøëéá úåøùúé. äøùúéú äéà ùëáä òöáéú äîëéìä úàéí øâéùéí ìàåø äîùîùú ëôéìí ùì îöìîä - ÷åìèú åîòáãú àú ëì îä ùàðå øåàéí. äîéãò äåéæåàìé ð÷ìè áä, îòåáã åòåáø ìîåç. äîçìä âåøîú áùìáéä äîå÷ãîéí éåúø ìñéðååø ìéìä, ìàçø îëï ìàéáåã øàéä äé÷ôéú, åáùìáéí îàåçøéí òùåéä ìäáéà ìòéååøåï îåçìè. éùðï òãåéåú ëé åéèîéðéí ðåâãé çîöåï òùåééí ìäàè àú ääéãøãøåú áøàéä, ëîå ìîùì åéèîéï A, àåìí áùìáéí îàåçøéí àéï ìöòøðå îä ìòùåú.

ð÷åãú îáè

øèéðéèéñ ôéâîðèåæä

îç÷øéí

ãó îéãò áðåùà

øèéðéèéñ ôéâîðèåæä

òéååøåï ìéìä

äòîåúä ìîç÷ø áøéàåú äòéï åîðéòú òéååøåï áéùøàì (ò"ø)

÷áåöú òðééï åúîéëä áðåùà

âéùåú çãùåú ìèéôåì áîçìåú òéðééí

ãó äîéãò ùì ôøåôñåø áìåîðèì

âéùåú ðéñéåðéåú ìèéôåì

îàîøé ñ÷éøä

øèéðéèéñ ôéâîðèåæä

äúùåáä ðéúðä òì éãé îéøé ëäï îöååú îéãòðé KOL

éùðí ðñéåðåú áîøëæéí ùåðéí áàøä"á åáàéøåôä ìôúç øàéä îìàëåúéú. äèëðåìåâéä äîú÷ãîú áéåúø ôåúçä áîëåï ãåäéðé áàåðéáøñéèú ÷ìéôåøðéä. äôéúåç ùìäí ëåìì îöìîä æòéøä äîùãøú àú äúîåðä ìîëùéø äðéùä òì äçåøä (áâåãì èìôåï ñìåìøé ÷èï). æä îùãø àú àåúåú äúîåðä äîòåáãú ìäú÷ï äîåùúì îúçú ìøùúéú ùáòéï. úàé äòöá áøùúéú îòáéøéí àú äàåúåú ìîåç. ìîòùä, áùéèä æå ðéúï ìäâéòä ìøàéä ùì àåø åöì, ìòéúéí âí ÷ååé îúàø, àê ìà îãåáø áøàéä ëôé ùàðå úåôñéí àåúä (ìãåâîä öôéä áèìååéæéä).

äúùåáä ðéúðä òì éãé îåîçä KOL ãø' ãåéã öãå÷

[17052]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

ùìåí.
àðé çééì ì÷øàú ùéçøåø

ùìåí.
àðé çééì ì÷øàú ùéçøåø ùîúìáè áàéæä ëéååï ììîåã áàåðéáøñéèä.
ëãé ìãòú ìàéæä ëéååï ììëú àðé øåöä ìãòú àí éù ãáøéí äòìåìéí ìäâáéì àåúé ò÷á ëê ùéù ìé áòéú øàééä ùì 6/15 òí îù÷ôééí áòéï àçú ò÷á äôøãåú øùúéú åâéìåé îàåçø. áòéï äùðéä àðé øåàä 6/6 òí îù÷ôééí.
ìîãúé áîâîú îçùáéí (èë"í), ëìåîø:
îãòé äîçùá 5 éç"ì, ôéñé÷ä 5 éç"ì, ðéúåç îòøëåú 5 éç"ì, îúéîèé÷ä åàðâìéú 5 éç"ì.
áëì äî÷öåòåú äð"ì éù ìé öéåðéí âáåäéí îàåã ùåàôéí ì100
éù ìé îîåöò öéåðéí âáåä îàåã áúòåãú áâøåú åàôéìå ÷éáìúé úòåãú äöèééðåú îîðë"ìéú îùøã äçéðåê.
äúîééðúé áöáà ìîîø"î àê ìà äú÷áìúé, åðàîø ìé ùæä éëåì ìäéåú ÷ùåø ìáòéú äøàééä ùìé.
äééúé øåöä ìùàåì àí éù òéñå÷éí àéðèì÷èåàìéí ùéëåìä ìäéåú ìé áòéä ìäâéò ìèåô áäí ò÷á áòééú äøàééä ùìé. åàí éù ñôøåú áðåùà ùàðé éëåì ìôðåú àìéä.
áúåãä îøàù.
øåï îùâá.

àéðèì÷èåàì äåà àãí áòì øòéåðåú, îçùáåú, ùéåöø åîñîì àú äâáåì äúô÷åãé ùì äîçùáä äàðåùéú. äåà éåöø åîôúç äáäøåú çáøúéåú ùòìéäï ðùòðú äúøáåú. äàéðèì÷èåàì äåà îåáéì çáøúé åúøáåúé: äåà ëåúá ñôøéí, îôøñí îàîøéí åôøñåîéí, îùôéò åîëååï àú ãòú ä÷äì åîòøëú äçéðåê. àéðèì÷èåàì äåà ùí ëåìì ìäåâé ãòåú, ñåôøéí, îùåøøéí, äéñèåøéåðéí, çå÷øé úøáåú åòúéãðéí. ëì çáøä úøáåúéú îëéìä áúåëä ùëáú àéðèì÷èåàìéí îùëéìä àùø ÷éåîä îáèéç ìäåáéì àú àåúä äçáøä ìùâùåâ åôøéçä, åäòãøä ìù÷éòú àåúä äúøáåú.

ìëï ìà ðù÷ôú ìê áòéä áî÷öòåú àéðèì÷èåàìéí.

àúä éëåì ì÷øåà òåã áðåùà:
ôåì â''åðñåï, àéðèì÷èåàìéí, äåöàú ãáéø, 1996.
ùìîä æðã, äàéðèì÷èåàì, äàîú åäëåç - îôøùú ãøééôåñ åòã îìçîú äîôøõ, äåöàú òí òåáã, 2000.

äúùåáä ðéúðä òì éãé âåìééèä îøãëééá îöååú îéãòðé KOL

áäîùê ìúùåáä ùðéúðä ìê, àåìé éòæåø ìê âí ìãòú òì òîåúú òì"ä ùáàåðéáøñéèä äòáøéú. òîåúú òì"ä îñééòú ìñèåãðèéí áòìé ì÷åéåú øàééä ìäúîåãã åìäöìéç áìéîåãéäí äà÷ãîééí. ìîøåú ùéúëï åàéðê ðëìì á÷øéèøéåðéí ùìäí ìñèåãðèéí áòìé ì÷åú øàééä äî÷áìéí ñéåò, éúëï åäí éåëìå âí ìúú ìê ééòåõ î÷öåòé ðåñó áðåâò ìùàìúê.
÷éùåø ìàúø ùìäí:
http://sites.huji.ac.il/blind

äúùåáä ðéúðä òì éãé àìéàá áøîï îöååú îéãòðé KOL

ìãòúé àúä öøéê ìùàåì àú òöîê ëîä ùàìåú:
1. äàí éù îøôà ìáòééä?
àðé äáðúé ùàôùø ìôúåø àåúä òì éãé ðéúåç:
http://www.6x6.co.il/eyedisease/rd.asp

2. äàí ääðçä ùìê ùàé ÷áìúê ìîîø"í äéà áâìì áòééú äøàééä ðñîëú òì ðéçåù ùì îùäå, àå ùæä ðàîø ìê ò"é âåøîéí îåñîëéí áöáà?

3. îä òùéú áöáà? ëéöã ì÷åé äøàéä ùìê ìà äôøéò ùí?
àåìé æä âí îçùáä ìëéååï úòñå÷úé áàæøçåú.

4. àí àúä øåàä îöåééï åòúéã ìèôì ááòééú äøàééä ùìê äøé àúä éëåì ìôúç àåìé ÷øééøä áúçåí äæä. àúä éëåì àåìé ìòùåú ãå÷èåøè áîçùáéí åëå''. ëê ùìéîåãéí à÷ãîééí ìãòúé öøéëéí ìáà àöìê áî÷åí äøàùåï, ùëï ðøàä ìé ùáà÷ãîéä éåúø ÷ì ìäú÷ãí ìàãí òí ì÷åú øàééä.
åùåá: áãå÷ ÷åãí àí àôùø ìú÷ï àú äì÷åú áöåøä ùìà úãøãø àú îöáê.

äúùåáä ðéúðä òì éãé çáéáä òáøé îöååú îéãòðé KOL

[16263]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

àåáçðä àöìé âìàå÷åîä ìôðé

àåáçðä àöìé âìàå÷åîä ìôðé ëòùø ùðéí åàðé îèåôì áòæøú èéôåú òéðééí Alphagan, Cosopt, Xalatan. òëùå àåáçï âí ÷èø÷è áùúé äòéðééí. äøåôà îîìéõ ìäîùéê ø÷ áèéôåì áèéôåú äðåâòåú ìâìàå÷åîä. øåôà ðåñó ùáé÷ùúé ìäúééòõ òîå îàùø ùéù ÷èø÷è áùúé äòéðééí åîîìéõ òì ðéúåç, ìãáøéå ãçééú äðéúåç ìà úáéà ëì úåòìú. äéåú åàðé ìà îøâéù ëì äøòä áøàééä, äàí øöåé ìòáåø ëáø òúä ðéúåç ìäñøú ä÷èø÷è?

ùìåí éåçðï.
àðé îîìéöä ìê ìäúééòõ áòðééðéí øôåàééí åòãéðéí ø÷ òí îåîçéí áòðééï.
àðé îöøôú ìê ÷éùåøéí ìàúøéí áäí úåëì ìäúééòõ òí àðùé î÷öåò.
øôåàä ùìéîä
àîåðä ëäï.

äãñä

äìì éôä áçãøä

äúùåáä ðéúðä òì éãé àîåðä ëäï îöååú îéãòðé KOL

[15264]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

äéúé øåöä ìãòú

äéúé øåöä ìãòú éåúø òì âìàå÷åîä ôúåçú æåéú áúåãä îøàù

ùáé ùìåí,

áàúø ùì äô÷åìèä ìøôåàä ùì àåðéáøñéèú éøåùìéí, úåëì ìîöåà îöâú áðåùà âìàå÷åîä, úåê ùéîú ãâù òì äàáçåï åäèéôåì.

áàúø ùì îøëæ øôåàé äãñä, úåëì ìîöåà àú îøôàú âìàå÷åîä, ùîîå÷îú áäãñä òéï ëøí, áðééï äîøôàåú, ÷åîä á' (áéðééí). îúçåîé ôòéìåúä – âìàå÷åîä øàùåðéú ôúåçú æåéú. ìîéãò åôøèéí ðåñôéí úåëì ìéöåø ÷ùø òí äîøôàä:
éîé ôòéìåú: á,ã 8:00-15:00
èì: 02-5842111

áàúø ùì MayoClinic, úåëì ìîöåà ù:
"Glaucoma is sometimes called the silent thief because it can slowly steal your sight before you realize anything's wrong. The most common form of glaucoma, primary open-angle glaucoma, develops gradually, giving no warning signs. Many people aren't even aware they have an eye problem until their vision is extensively compromised… Primary open-angle glaucoma progresses with few or no symptoms until the condition reaches an advanced stage. As increased eye pressure continues to damage your optic nerve, you lose more and more of your peripheral vision. If glaucoma is left untreated you can develop tunnel vision, and eventually lose all sight. Open-angle glaucoma usually affects both eyes, although at first you may have vision loss in just one eye."
îéãò ðåñó òì Signs and symptoms ,Causes ,Risk factors , When to seek medical advice, Screening and diagnosis ,Treatment ,Prevention å-Self care úåëì ìîöåà áàúø.

áàúø ùì Patient UK, úåëì ìîöåà ëé:
"Primary open angle glaucoma (also called chronic glaucoma) is the most common type. This develops slowly so that any damage to the nerve and loss of sight is gradual. The term ''open angle'' refers to the angle between the iris and sclera which is normal

What happens in primary open angle glaucoma?
In primary open angle glaucoma (just called ''glaucoma'' from now on) there is a partial blockage within the trabecular meshwork. This restricts the drainage of aqueous humour. The reason why the trabecular meshwork becomes blocked and does not drain well is not fully understood. The pressure of the aqueous humour builds up if the drainage is faulty. But, this also increases the pressure on the back of the eye.
The increased pressure in the eye can damage the optic nerve (the main nerve of sight) and the nerve fibres running towards it from the retina. The retina contains the ''seeing'' cells at the back of the eye. The damaged parts of the nerve and retina lead to permanent patches of vision loss. In some cases this can eventually lead to total blindness.

Who gets primary open angle glaucoma?
In the UK, about 1 in 50 people over 40 have glaucoma. It is unusual in people under the age of 35. It becomes more common with increasing age. Glaucoma can affect anyone, but it is more common if you:
• Have a family history of glaucoma.
• Have very short sight.
• Have diabetes.
• Are from African or Afro-Caribbean origin.

What are the symptoms of primary open angle glaucoma?
At first there are usually no symptoms. There is no pain or redness in the eye. Most people with glaucoma do not notice problems until quite a bit of visual loss has occurred. This is because the first part of the vision to ''go'' is the outer (peripheral) field of vision. Central vision, used to focus on an object such as when we read, is spared until relatively late in the disease. Also, although glaucoma usually affects both eyes, it may not affect them equally. The better eye may ''fill in'' for a while if the other eye starts to lose patches of visual field.
Some elderly people with glaucoma put their gradual failing vision down to ''just getting old''. They might not have had their eyes checked for many years and may needlessly lose their sight. Untreated glaucoma is one of the world's leading causes of blindness.
But, blindness can be prevented if glaucoma is diagnosed and treated early enough.

What is the treatment for primary open angle glaucoma?
The aim of treatment is to lower the eye pressure. If the eye pressure is lowered, further damage to the optic nerve is likely to be prevented or delayed. The eye pressure to ''aim for'' varies from case to case. It partly depends on how high the original pressure is. Your eye specialist will advise. Eye pressure can be lowered in various ways

Eye drops
A variety of eye drop can lower eye pressure. They work either to:
• Reduce the amount of aqueous humour that you make
• Increase the drainage of aqueous humour.
Your eye specialist will advise. Some drops work better in some people than in others. Some drops are not suitable if you have asthma. Also, the possible side-effects vary between the different types of drops. So, if the first does not work so well, or does not suit, another may work fine. In some cases, two different types of drops are needed to keep the eye pressure low.
It is vital to use your drops exactly as instructed. If you are unsure that you are using your drops correctly, ask for advice from your doctor or practice nurse. An eye specialist will keep a regular check on your eye pressures, optic nerves, and field of vision.

Tablets
These are sometimes used. They work by reducing the amount of aqueous humour that you make.

Surgery
An operation called trabeculectomy is an option. This involves creating a channel between just inside of the eye to just under the conjunctiva. So, the aqueous humour can bypass the blocked trabecular meshwork. In effect, it is like forming a small ''safety-valve'' for the aqueous humour.
Surgery may be advised if a trial of eye drops has failed to achieve target eye pressures, especially in younger people, or if you have very high eye pressures.
Like with all operations, there is a small risk of complications. Also the operation may have to be repeated in some cases. This is usually because some scar tissue forms at the site of the channel and prevents it working to drain the aqueous humour.

Laser treatments
A laser can ''burn'' the trabecular meshwork which improves the drainage of the aqueous humour. Another technique is to destroy parts of the ciliary body which reduces the amount of aqueous humour that is made. However, the reduction in eye pressure after laser treatments often only lasts a short time. So, laser treatments are not commonly done. "
ìòæøä åîéãò ðåñó, úåëì ìôðåú ì- International Glaucoma Association
ëúåáú: 108c Warner Road, London, SE5 9HQ
èìôåï: 0207 737 3265
ãåà"ì: www.iga.org.uk

îéãò ðåñó úåëì ìîöåà áàúø ùì eMedicine, eyeMDlink å-Review of Optometry.

ùéäéä áäöìçä!

äô÷åìèä ìøôåàä ùì àåðéáøñéèú éøåùìéí – âìàå÷åîä åèéôåìéí úøåôúééí – ã"ø äãñ îùåìí

îøëæ øôåàé äãñä – îçì÷åú åùéøåúéí øôåàééí – îøôàåú + îëåðéí – òéðééí – òéðééí – òéï – îøôàú âìàå÷åîä

MayoClininc – Glaucoma

Patient UK – Glaucoma (Primary Open Angle)

eMedicine – Glaucoma, Primary Open Angle Article by Jerald A Bell, MD

eyeMDlink – Eye Condition – Primary Open Angle Glaucoma

Review of Optometry – Handbook of Ocular Disease Management – Primary Open Angle Glaucoma (POAG)

äúùåáä ðéúðä òì éãé øçì ãøåñ÷éï îöååú îéãòðé KOL

[13836]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

ùìåí ùîé éåàá âøåñ

ùìåí ùîé éåàá âøåñ îáéú ñôø àåøè ðúðéä áëéúä è.
àðé îùúúó áôøåé÷è àøöé ùì áðééú àáéæøéí ìàðùéí áòìé öøëéí îéåçãéí.
àðé îôúç îåöø ìòéååøéí åìëï äððé æ÷å÷ ìîéãò òì îòøëú äøàééä, âåøîéí ìòéååøåï, àéáøé îòøëú äøàééä,ø÷îåú åúàéí ùéù áîòøëú äøàééä åúîåðåú áðåùà.
àåãä ìëí îàåã àí úùìçå ìé îéãò æä áä÷ãí äàôùøé.
úåãä îøàù éåàá âøåñ

éåàá, ùìåí øá,

ìäìï îñôø ÷éùåøéí ìàúøéí äëåììéí çåîø øá, îàîøéí åúîåðåú, áðåùà øàéä åòéååøåï:
1. ð÷åãú îáè - äàúø äéùøàìé ìøôåàú òéðééí:
http://www.eyes.co.il
áàúø æä éù îàîøéí øáéí åçùåáéí, îéãò øôåàé øá, ëåìì ðéúåçéí, îçìåú òéðééí åòåã. îåîìõ îàåã ìãôãó áëì äàúø.
áàúø ÷ééí âí îéìåï îåðçéí, ÷éùåøéí ìàúøéí øáéí åëï îéãò ìâáé îáðä äòéï.
2. îéãò æä, ëåìì úîåðä ùì îáðä äòéï - îåôéò á÷éùåø äáà:
ð÷åãú îáè - îáðä äòéï:
http://www.eyes.co.il/stuff/eye-structure.asp

3. òì øàéä - îàúø "îëåï îåôú":
http://www.macam98.ac.il/chtml/eyes/vision.htm
æäå àúø ùðéúï ìäâéò àìéå âí ëàùø îãôãôéí áàúø "ð÷åãú îáè". éù áå úîåðåú ùì øùúéú äòéï åäòéï òöîä.

4. äîøëæ ìòéååø áéùøàì:
http://www.blinds.org.il
àúø ðåñó çùåá îàåã åáå éùðí ÷éùåøéí ìàúøéí ðåñôéí, ëê ùúåëì ìäâéò ìòåã îéãò áðåùà äîáå÷ù.

ëì äàúøéí äììå äí àúøéí éôéí, áøåøéí, äëì áòáøéú åáçì÷ îäí éù âí àôùøåú ôðéä ìîåîçéí.


ëì èåá!

äúùåáä ðéúðä òì éãé îéëì àðâìîï îöååú îéãòðé KOL

[12411]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

ùîé ìéàåø àðé úìîéã

ùîé ìéàåø àðé úìîéã ëéúä è á÷øééú äçéðåê òì ùí áï âåøéåï.
ëéúúé îùúúôú áôøåé÷è àøöé ùì ôéúåç îëùéøé òæø ìàðùéí òí öøëéí îéåçãéí, áçøðå ìäúî÷ã áðåùà îòøëú äøàééä åòéååøåï àåãä ìëí îàåã àí úùìçå ìðå àúøéí ñéëåîéí åçåîø áðåùà.
áúåãä îøàù ìéàåø øåéèîï.

ùìåí ìéàåø,

àðé îöøôú îñôø àúøéí ùëåììéí çåîø øá, îàîøéí åúîåðåú, äëì áðåùà øàéä åòéååøåï. äàúø äøàùåï äåà äàúø äéùøàìé ìøôåàú òéðééí. áàúø æä éù îàîøéí øáéí åçùåáéí, îéãò øôåàé øá, ëåìì ðéúåçéí, îçìåú òéðééí åòåã. îåîìõ îàåã ìãôãó áëì äàúø. òåã úîöà áàúø îéìåï îåðçéí, ÷éùåøéí ìàúøéí øáéí åëï îéãò ìâáé îáðä äòéï. îéãò æä ìøáåú úîåðä ùì îáðä äòéï îåôéòéí á÷éùåø äùðé. á÷éùåø äøáéòé öéøôúé àúø, ùðéúï ìäâéò àìéå âí ëàùø îãôãôéí áàúø "ð÷åãú îáè". äàúø äæä (äøáéòé) îàåã çùåá åîòðééï. éù áå úîåðåú ùì øùúéú äòéï åäòéï òöîä. àúø ðåñó îàåã çùåá, äåà äàúø ùì äîøëæ ìòéååø áéùøàì. áàúø æä éù ÷éùåøéí ìàúøéí àçøéí, åëê úâéò ìòåã îéãò áðåùà äîáå÷ù. ëì äàúøéí äàìå äí àúøéí éôéí, áøåøéí, äëì áòáøéú åáçì÷ îäí éù âí àôùøåú ôðéä ìîåîçéí.


éåí èåá,

òðú

ð÷åãú îáè - äàúø äéùøàìé ìøôåàú òéðééí

ð÷åãú îáè - îáðä äòéï

äîøëæ ìòéååø

òì øàéä îàúø "îëåï îåôú"

äúùåáä ðéúðä òì éãé îöååú îéãòðé KOL

[12405]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

ùìåí,
÷ðéúé ñôø åùîå

ùìåí,
÷ðéúé ñôø åùîå "øàééä îùåôøú ììà îù÷ôééí" äîúáññ òì äùéèä ùì ã"ø áééèñ åòåã ùéèåú ùåðåú ìèéôåì áøàééä åùéôåøä.
àðé îáöò àú äúøâéìéí ùäåà ðúï ùí ëáø ùáåòééí, åàðé îñúåáá áìé äîù÷ôééí ááéú áìé ùåí áòéä. ëàùø àðé ùí àú äîù÷ôééí ùìé - àðé îøâéù ëàéìå àðé øåàä áøåø éåúø îî÷åãí.
ùàìúé äéà: äàí ëàùø àðé äåìê òí äîù÷ôééí ìàçø äèéôåì ìîùê æîï àøåê (ëìåîø ëîä ùòåú) - æä îçæéø àú äøàéä ì÷ãîåúä? (ëìåîø ôçåú èåáä).
ùàìä ðåñôú: äàí îðñéåðê ùéèåú àìä òåáãåú? åàí ëï - òì àéæä ñôø ùòåñ÷ áðåùà àúä îîìéõ?

ùé, ùìåí øá,

ìôé äîàîø äáà, äòåñ÷ áùéèú áééèñ, éùðå îéðåï îñåééí ùìôéå îåøéãéí àú äîù÷ôééí áäúàí ìäú÷ãîåú áúøâåìéí:
http://www.alternativit.co.il/Bates.htm

ôåøåí âåìùéí ìùéèú áééèñ:
http://www.tevalife.com/forum/topic.asp?FORUM_ID=281&tevalife=yes

îàîøéí ðåñôéí:
äôñéëåìåâéä ùì äøàééä:
http://www.alternativit.co.il/Michaely.htm

äàí äøëáú îù÷ôééí äåà äôúøåï?:
http://www.alternativit.co.il/Michaely1.htm

àîðåú äøàééä:
http://www.6x6.co.il/altmed/eyeart.asp

ùéôåø äøàééä äèáòéú:
http://www.6x6.co.il/altmed/baits.asp

øàééä ììà îù÷ôééí:
http://www.i-see.org/perfect_sight/

ñôøéí ðåñôéí áúçåí:
éò÷á ùìçéï, ùéôåø äøàééä ìôé ùéèú áééèñ - ñôø äãøëä ùéîåùé ìùéôåø øàééä ì÷åéä
îàéø ùðééãø, äçééí ëúðåòä
îàéø ùðééãø, î. ìø÷éï, ã. ùðééãø, øéôåé òöîé áúðåòä (2 ëøëéí)
äàøé áðâ'îéï, øàééä îùåôøú ììà îù÷ôééí, äåöàú àåø-òí


ëì èåá!

äúùåáä ðéúðä òì éãé îéëì àðâìîï îöååú îéãòðé KOL

[12309]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

äàí îçìú äøùúéú Retinitis

äàí îçìú äøùúéú Retinitis Pigmentosa ôåâòú áàåôï îñåéí áäúôúçåú äôéæéåìåâéú-÷åâðèéáéú ùì âåó äàãí îòáø ìòéðééí áìáã?

éåñé ùìåí øá!
retenitis pigmentosa äéðå ùí ëììé ì÷áåöú îçìåú ùäîùåúó ìäï äéà ôâéòä áøùúéú äòéï. äôâéòä äôéæéú îúáèàú ø÷ áøàééä - áòé÷ø ÷ùééí áøàééú ìéìä åôâéòä áøàééä äîøçáéú. îáçéðä ÷åâðéèéáéú , ñáéø ìäðéç ù÷ééîú äùôòä ëìùäéà òì ääúôúçåú, áòé÷ø ëàùø äîçìä îåôéòä áùìá îå÷ãí áéìãåú, àê øåá äîç÷øéí åäîîöàéí îøàéí ëé ðéúï ìäúîåãã òí äîçìä áãøëéí ùåðåú åàéï ëì îðéòä ùéìãéí äçåìéí áîçìä éúôúçå ôéæéú åîðèìéú ëîå ëì éìã øâéì.
îö"á ÷éùåøéí ìîéãò ä÷ùåø áðåùà, ìòéåðê.

àúø ùì ùàìåú åúùåáåú ä÷ùåøåú ìîçìä

àúø äîáéà ñéôåøéí àéùééí ùì àðùéí äçåìéí áîçìä åîñôøéí òì ääúîåããåú åòì äçééí áöéìä

ôåøåí ìçåìé Retinitis Pigmentosa äîàôùø ìú÷ùø òí çåìéí áîçìä å/àå ìùàåì ùàìåú áðåùà

òåã àúø äîñô÷ úùåáåú á÷ùø ìîçìä

äúùåáä ðéúðä òì éãé ãðä àééæðø îöååú îéãòðé KOL

[12241]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

àùîç àí àåëì ì÷áì

àùîç àí àåëì ì÷áì ôøèéí òì äîçìä ä÷øåéä áùí äáà:
Retinitis Pigmentoza
äàí éù ôúøåï å/àå èéôåì äî÷ì òì äñåáìéí? àùîç âí ì÷áì äôðéä ìàúøéí áòáøéú òì äîçìä

éåñé ùìåí,

øèéðéèéñ ôéâîðèåæä äéà ÷áåöú îçìåú ùäîùåúó ìäï äåà ðéååï äøùúéú äðåáò îôâí äîùôéò òì øàééú äìéìä åòì äøàééú ääé÷ôéú. æäå ôâí âðèé äîåòáø áã"ë áúåøùä. äúñîéðéí (ñéîôèåîéí) äí àáãï úéô÷åã ôåèå-øöôèåøéí (úàé ÷åìèé àåø áøùúéú), ãáø äâåøí ìöéîöåí ùãä äøàééä. áäîùê ôâéòä áøàééú ìéìä, åìáñåó òìåì ìäâøí òéååøåï.
äîçìä çùåëú îøôà. àéï òãééï èéôåì îåëç áøèéðéèéñ ôéâîðèåæä, ìîøåú ù÷ééîéí ðéñåééí ùåðéí áäùúìú úàéí ÷åìèé àåø àå äùúìú âðéí. àúø àçú äçáøåú äòåøëåú ðéñåééí áúçåí: http://www.optobionics.com

îç÷ø ùôåøñí á-1993 îöà ëé öøéëä îøåáä ùì åéèîéï A åöøéëä îáå÷øú ùì åéèîéï E òí äåôòú äñéîðéí äøàùåðéí ùì äîçìä òùåéä ìäàè àú ÷öú äãøãøåú äøàééä. ú÷öéø äîç÷ø: http://archopht.ama-assn.org/cgi/content/abstract/111/6/761. ôéøåè ðåñó: http://www.jwen.com/rp/vita/vita.html

îéãò áàéðèøðè (áòáøéú) ðéúï ì÷áì, áéï äéúø, áôåøåí øôåàú òéðééí áàúø www.doctors.co.il, áå ðòæøðå âí àðå áäëðú úùåáä æå: http://www.doctors.co.il/forums/read.php?f=27

ì÷áìú àáçåï î÷öåòé, îéãò ðåñó åèéôåì àéùé éù ìôðåú ìîåîçä áøôåàú òéðééí.

ááøëä,

ùàìåú åúùåáåú ðåñôåú òì àåãåú øèéðéèéñ ôéâîðèåæä

äúùåáä ðéúðä òì éãé éàéø àáï-æåäø îöååú îéãòðé KOL

[12130]     ùìç ìçáø:     äãôñ: äåñó úâåáä:

[1] [2] >>
***
àéðã÷ñ îåîçéí øåàä çùáåï áåéãéàå ö'àè îàîï àéùé àåï ìééï îåîçéí ìàñèøåìåâéä îåîçä ìðåîåøåìâéä
÷åøàú ä÷ìôéí àåï ìééï øåôàéí îåîçéí áåéãéàå ö'àè àåøèåôã îåîçä àåï ìééï ðåéøåìåâ áåéãéàå ö'àè éòåõ òåøê ãéï áøùú
àúøéí îùìéîéí - ú÷ùåø ðåîøåìåâéä ÷ìôéí - ÷éùåøéí ùéîåùééí - ñôøéí áøùú - ùåúôéí - ðîåøåìåâéä - úéëåï åáâøåéåú - ú÷ùåø - îåîçéí - îùä ùøåï | ìéîåãé ÷áìä